Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
High mobility group box 3 pseudogene 8 (HMGB3P8) is classified as a pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they do not code for proteins due to accumulated mutations or the lack of regulatory features necessary for gene expression. There is no evidence that HMGB3P8 produces a functional protein or participates in cellular signaling, disease, or as a therapeutic target[1][3][6][7]. Pseudogenes often arise from duplication or retrotransposition events and are considered genetic "fossils" with no known productive function in human physiology[6][7]. Some pseudogenes in other cases can have regulatory RNA roles; there is no evidence for functional regulatory RNA activity or disease association for HMGB3P8[1][4]. All standard gene and protein databases classify HMGB3P8 as a pseudogene without known clinical or therapeutic significance[1][3][4]. This entry contains no evidence for any validated protein product, target activity, or relevance in pharmacology or medicine.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group box 3 pseudogene 8 (HMGB3P8).